Health & Fitness
Mon, October 1, 2012Sun, September 30, 2012Sat, September 29, 2012Fri, September 28, 2012Thu, September 27, 2012Wed, September 26, 2012Tue, September 25, 2012Mon, September 24, 2012Sun, September 23, 2012Fri, September 21, 2012Thu, September 20, 2012Wed, September 19, 2012Tue, September 18, 2012Mon, September 17, 2012Sun, September 16, 2012Fri, September 14, 2012Medisafe 1 Technologies Obtains Listing on Berlin Stock Exchange
//health-fitness.news-articles.net/content/2012/ .. es-obtains-listing-on-berlin-stock-exchange.html
Published in Health and Fitness on Monday, September 24th 2012 at 7:45 GMT by Market WireMedisafe 1 Technologies Obtains Listing on Berlin Stock Exchange -- JERUSALEM, September 24, 2012 /PRNewswire/ --
Medisafe 1 Technologies Obtains Listing on Berlin Stock Exchange
JERUSALEM, September 24, 2012 /PRNewswire/ --
Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company's common stock became eligible for trading on the Borse Berlin, or the Berlin Stock Exchange, under the symbol "MS1" and the German security number (WKN) "A1JPAQ".
The Berlin Stock Exchange has secondary stock listings for over 6,000 U.S. securities that are listed on such exchanges as the NYSE, NASDAQ, AMEX or quoted on the OTC Bulletin Board.
"Trading shares on the Berlin exchange provides Medisafe 1 Technologies with increased exposure to the European capital markets," said Jacob Elhadad, CEO of Medisafe 1 Technologies Corp. "We are hopeful that access to additional investment capital can increase the company's capabilities to further develop and market our proprietary, life-saving devices."
About Medisafe 1 Technologies
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at [ http://www.sec.gov ].
Contact:
Jacob Elhadad CEO
+972-524440000
[ Jacob.elhadad10@gmail.com ]
SOURCE Medisafe 1 Technologies Corp.
[ Back to top ]
